{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:25:34Z","timestamp":1790144734370,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lung cancer is the leading cause of cancer-related deaths among men and women in the world, accounting for the 25% of cancer mortality. Early diagnosis is an unmet clinical issue. In this work, we focused to develop a novel approach to identify highly sensitive and specific biomarkers by investigating the use of extracellular vesicles (EVs) isolated from the pleural lavage, a proximal fluid in lung cancer patients, as a source of potential biomarkers. We isolated EVs by ultracentrifuge method from 25 control pleural fluids and 21 pleural lavages from lung cancer patients. Analysis of the expression of EV-associated miRNAs was performed using Taqman OpenArray technology through which we could detect 288 out of the 754 miRNAs that were contained in the OpenArray. The differential expression analysis yielded a list of 14 miRNAs that were significantly dysregulated (adj. p-value\u2009&lt;\u20090.05 and logFC lower or higher than 3). Using Machine Learning approach we discovered the lung cancer diagnostic biomarkers; miRNA-1-3p, miRNA-144-5p and miRNA-150-5p were found to be the best by accuracy. Accordance with our finding, these miRNAs have been related to cancer processes in previous studies. This results opens the avenue to the use of EV-associated miRNA of pleural fluids and lavages as an untapped source of biomarkers, and specifically, identifies miRNA-1-3p, miRNA-144-5p and miRNA 150-5p as promising biomarkers of lung cancer diagnosis.<\/jats:p>","DOI":"10.1038\/s41598-019-51578-y","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T12:11:10Z","timestamp":1571659870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer"],"prefix":"10.1038","volume":"9","author":[{"given":"Berta","family":"Roman-Canal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian Pablo","family":"Moiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f2nia","family":"Gatius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5159-2518","authenticated-orcid":false,"given":"Sarah","family":"Bonnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ruiz-Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Ojanguren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Recuero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1106-5590","authenticated-orcid":false,"given":"Antonio","family":"Gil-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-0670","authenticated-orcid":false,"given":"Juan M.","family":"Falc\u00f3n-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ponomarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Porcel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Colas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"51578_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018: Cancer Statistics, 2018. CA. Cancer J. Clin. 68, 7\u201330 (2018).","journal-title":"CA. Cancer J. Clin."},{"key":"51578_CR2","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00280-014-2559-9","volume":"74","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Yang, Q. & Wang, S. MicroRNAs: a new key in lung cancer. Cancer Chemother. Pharmacol. 74, 1105\u20131111 (2014).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"51578_CR3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","volume":"28","author":"PE Postmus","year":"2017","unstructured":"Postmus, P. E. et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann. Oncol. 28, iv1\u2013iv21 (2017).","journal-title":"Ann. Oncol."},{"key":"51578_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.lungcan.2016.10.009","volume":"102","author":"K Tomizawa","year":"2016","unstructured":"Tomizawa, K. et al. Prognostic impact of pleural lavage cytology in patients with primary lung cancer. Lung Cancer 102, 60\u201364 (2016).","journal-title":"Lung Cancer"},{"key":"51578_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5761\/atcs.oa.17-00088","volume":"24","author":"T Inoue","year":"2018","unstructured":"Inoue, T. et al. Epidermal Growth Factor Receptor Gene Mutation in Pleural Lavage Cytology Findings of Primary Lung Adenocarcinoma Cases. Ann. Thorac. Cardiovasc. Surg. 24, 1\u20135 (2018).","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"51578_CR6","doi-asserted-by":"crossref","unstructured":"Qin, X., Xu, H., Gong, W. & Deng, W. The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer. Front. Oncol. 4 (2015).","DOI":"10.3389\/fonc.2014.00357"},{"key":"51578_CR7","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"51578_CR8","doi-asserted-by":"publisher","first-page":"27522","DOI":"10.3402\/jev.v4.27522","volume":"4","author":"T An","year":"2015","unstructured":"An, T. et al. Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J. Extracell. Vesicles 4, 27522 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"51578_CR9","doi-asserted-by":"publisher","first-page":"26659","DOI":"10.3402\/jev.v4.26659","volume":"4","author":"KR Jakobsen","year":"2015","unstructured":"Jakobsen, K. R. et al. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma. J. Extracell. Vesicles 4, 26659 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"51578_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3816\/CLC.2009.n.006","volume":"10","author":"G Rabinowits","year":"2009","unstructured":"Rabinowits, G., Ger\u00e7el-Taylor, C., Day, J. M., Taylor, D. D. & Kloecker, G. H. Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer. Clin. Lung Cancer 10, 42\u201346 (2009).","journal-title":"Clin. Lung Cancer"},{"key":"51578_CR11","doi-asserted-by":"publisher","unstructured":"Giallombardo, M. et al. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients\u2019 Plasma Through qPCR: A Feasible Liquid Biopsy Tool. J. Vis. Exp., https:\/\/doi.org\/10.3791\/53900 (2016).","DOI":"10.3791\/53900"},{"key":"51578_CR12","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-17-0577","volume":"23","author":"X Jin","year":"2017","unstructured":"Jin, X. et al. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non\u2013Small Cell Lung Cancer Using Next-Generation Sequencing. Clin. Cancer Res. 23, 5311\u20135319 (2017).","journal-title":"Clin. Cancer Res."},{"key":"51578_CR13","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-14-3380","volume":"75","author":"Y-S Chang","year":"2015","unstructured":"Chang, Y.-S. et al. EGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1. Cancer Res. 75, 3077\u20133086 (2015).","journal-title":"Cancer Res."},{"key":"51578_CR14","doi-asserted-by":"crossref","unstructured":"Li, S.-M. et al. The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1. J. Exp. Clin. Cancer Res. 37 (2018).","DOI":"10.1186\/s13046-018-0895-z"},{"key":"51578_CR15","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1158\/0008-5472.CAN-07-5680","volume":"68","author":"Y Arima","year":"2008","unstructured":"Arima, Y. et al. Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition. Cancer Res. 68, 5104\u20135112 (2008).","journal-title":"Cancer Res."},{"key":"51578_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1159\/000495273","volume":"51","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. miR-1-3p Contributes to Cell Proliferation and Invasion by Targeting Glutaminase in Bladder Cancer Cells. Cell. Physiol. Biochem. 51, 513\u2013527 (2018).","journal-title":"Cell. Physiol. Biochem."},{"key":"51578_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1159\/000464379","volume":"41","author":"A Shang","year":"2017","unstructured":"Shang, A. et al. MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression. Cell. Physiol. Biochem. 41, 1179\u20131188 (2017).","journal-title":"Cell. Physiol. Biochem."},{"key":"51578_CR18","doi-asserted-by":"publisher","first-page":"33394","DOI":"10.1074\/jbc.M804788200","volume":"283","author":"MW Nasser","year":"2008","unstructured":"Nasser, M. W. et al. Down-regulation of Micro-RNA-1 (miR-1) in Lung Cancer: Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 283, 33394\u201333405 (2008).","journal-title":"J. Biol. Chem."},{"key":"51578_CR19","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.3892\/mmr.2016.5691","volume":"14","author":"Z Gao","year":"2016","unstructured":"Gao, Z. et al. Possible tumor suppressive role of the miR-144\/451 cluster in esophageal carcinoma as determined by principal component regression analysis. Mol. Med. Rep. 14, 3805\u20133813 (2016).","journal-title":"Mol. Med. Rep."},{"key":"51578_CR20","doi-asserted-by":"crossref","unstructured":"Zhang, S.-Y. et al. miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma. Oncotarget 7 (2016).","DOI":"10.18632\/oncotarget.7025"},{"key":"51578_CR21","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1111\/cas.13722","volume":"109","author":"Y Yamada","year":"2018","unstructured":"Yamada, Y. et al. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance. Cancer Sci. 109, 2919\u20132936 (2018).","journal-title":"Cancer Sci."},{"key":"51578_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bjc.2015.195","volume":"113","author":"R Matsushita","year":"2015","unstructured":"Matsushita, R. et al. Tumour-suppressive microRNA-144-5p directly targets CCNE1\/2 as potential prognostic markers in bladder cancer. Br. J. Cancer 113, 282\u2013289 (2015).","journal-title":"Br. J. Cancer"},{"key":"51578_CR23","first-page":"1","volume":"2018","author":"L Song","year":"2018","unstructured":"Song, L. et al. miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2. BioMed Res. Int. 2018, 1\u201310 (2018).","journal-title":"BioMed Res. Int."},{"key":"51578_CR24","doi-asserted-by":"crossref","unstructured":"Gao, Z. et al. miR-144\/451 cluster plays an oncogenic role in esophageal cancer by inhibiting cell invasion. Cancer Cell Int. 18 (2018).","DOI":"10.1186\/s12935-018-0679-8"},{"key":"51578_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ejca.2013.12.024","volume":"50","author":"M Cao","year":"2014","unstructured":"Cao, M. et al. miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1. Eur. J. Cancer 50, 1013\u20131024 (2014).","journal-title":"Eur. J. Cancer"},{"key":"51578_CR26","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.febslet.2013.05.059","volume":"587","author":"N Zhang","year":"2013","unstructured":"Zhang, N., Wei, X. & Xu, L. miR-150 promotes the proliferation of lung cancer cells by targeting. P53. FEBS Lett. 587, 2346\u20132351 (2013).","journal-title":"P53. FEBS Lett."},{"key":"51578_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","volume":"9","author":"N Yanaihara","year":"2006","unstructured":"Yanaihara, N. et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189\u2013198 (2006).","journal-title":"Cancer Cell"},{"key":"51578_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.gene.2016.04.058","volume":"587","author":"M Sakr","year":"2016","unstructured":"Sakr, M. et al. miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase. Gene 587, 155\u2013162 (2016).","journal-title":"Gene"},{"key":"51578_CR29","doi-asserted-by":"publisher","first-page":"15019","DOI":"10.1007\/s13277-016-5313-6","volume":"37","author":"X Wu","year":"2016","unstructured":"Wu, X. et al. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma. Tumor Biol. 37, 15019\u201315029 (2016).","journal-title":"Tumor Biol."},{"key":"51578_CR30","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/gutjnl-2011-301122","volume":"61","author":"Y Ma","year":"2012","unstructured":"Ma, Y. et al. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer. Gut 61, 1447\u20131453 (2012).","journal-title":"Gut"},{"key":"51578_CR31","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. miR\u2010150\u20105p suppresses tumor progression by targeting VEGFA in colorectal cancer. Aging (Albany NY). 10(11), 3421\u20133437. https:\/\/doi.org\/10.18632\/aging.101656 (26 Nov 2018).","DOI":"10.18632\/aging.101656"},{"key":"51578_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1183\/09031936.03.00041703","volume":"22","author":"C Admyre","year":"2003","unstructured":"Admyre, C. et al. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid. Eur. Respir. J. 22, 578\u2013583 (2003).","journal-title":"Eur. Respir. J."},{"key":"51578_CR33","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/1759-7714.12756","volume":"9","author":"JE Kim","year":"2018","unstructured":"Kim, J. E. et al. Diagnostic value of microRNAs derived from exosomes in bronchoalveolar lavage fluid of early-stage lung adenocarcinoma: A pilot study: BAL exosomal miRNAs of lung ADC. Thorac. Cancer 9, 911\u2013915 (2018).","journal-title":"Thorac. Cancer"},{"key":"51578_CR34","doi-asserted-by":"crossref","unstructured":"Campoy, I. et al. Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols. J. Transl. Med. 14 (2016).","DOI":"10.1186\/s12967-016-0935-4"},{"key":"51578_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1954-8","volume":"17","author":"B Roman-Canal","year":"2019","unstructured":"Roman-Canal, B. et al. EV-associated miRNAs from peritoneal lavage as potential diagnostic biomarkers in colorectal cancer. J. Transl. Med. 17, 208 (2019).","journal-title":"J. Transl. Med."},{"key":"51578_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/cancers11060839","volume":"11","author":"B Roman-Canal","year":"2019","unstructured":"Roman-Canal, B. et al. EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer. Cancers 11, 839 (2019).","journal-title":"Cancers"},{"key":"51578_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber, W. et al. Orchestrating high-throughput genomic analysis with Bioconductor. Nat. Methods 12, 115\u2013121 (2015).","journal-title":"Nat. Methods"},{"key":"51578_CR38","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1093\/bioinformatics\/btp578","volume":"25","author":"H Dvinge","year":"2009","unstructured":"Dvinge, H. & Bertone, P. HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. Bioinformatics 25, 3325\u20133326 (2009).","journal-title":"Bioinformatics"},{"key":"51578_CR39","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"51578_CR40","doi-asserted-by":"crossref","unstructured":"Benjaminit, Y. & Yosef Hochberg, J. R. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing Statist. Soc. B 57(1), 289\u2013300 (1995).","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"51578_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nmeth.3485","volume":"12","author":"H Dweep","year":"2015","unstructured":"Dweep, H. & Gretz, N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat. Methods 12, 697\u2013697 (2015).","journal-title":"Nat. Methods"},{"key":"51578_CR42","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nprot.2013.092","volume":"8","author":"H Mi","year":"2013","unstructured":"Mi, H., Muruganujan, A., Casagrande, J. T. & Thomas, P. D. Large-scale gene function analysis with the PANTHER classification system. Nat. Protoc. 8, 1551\u20131566 (2013).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51578-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51578-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:49:58Z","timestamp":1671288598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51578-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51578"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51578-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"24 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15057"}}